record

Brighter Heights Maine - Yarmouth

Yarmouth, ME

Medication used in treatmentDirectory coverage. Read the methodology and limitations.

Facility contact

Care types: Substance use treatment, Treatment for co-occurring disorders plus serious mental illness (SMI) in adults Source
Care settings: Outpatient, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment Source
OUD medication support: Medication used in treatment Source
Opioid medications: Buprenorphine used in Treatment, Naltrexone used in Treatment Source
Opioid treatment responses: Buprenorphine maintenance, Prescribes buprenorphine, Lofexidine or Clonidine detoxification Source
Other pharmacotherapies: Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable), Clonidine, Medication for mental disorders, Nicotine replacement Source
Treatment approaches: Cognitive behavioral therapy, Motivational interviewing, Relapse prevention, Substance use disorder counseling, Trauma-related counseling, Telemedicine/telehealth therapy Source

Payment methods: Federal, or any government funding for substance use treatment programs, Medicaid, Cash or self-payment, State-financed health insurance plan other than Medicaid Source
Payment assistance: Sliding fee scale (fee is based on income and other factors) Source
Telehealth reported: Yes Source
Transportation assistance: No Source
Ancillary services: Case management service, Mental health services, Suicide prevention services Source

Age groups: Young Adults, Adults Source
Co-occurring treatment reported: Yes Source
Reported independent accreditors: The Joint Commission Source
All oversight and accreditation responses: State substance use treatment agency, State mental health department, The Joint Commission Source
Facility operation: Private for-profit organization Source
Directory field completeness: 100 / 100 Source

Research workflow

Unlock shortlist comparison, local notes, export, and complete directory context.